Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	May 26, 2017	May 27, 2016	May 26, 2017	May 27, 2016
Cash flows from operating activities:
Net income (loss)	$ 7,958	$ (1,345)	$ 2,414	$ (18,499)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	7,846	7,709	25,399	23,390
Share-based compensation	1,389	947	3,533	2,970
Provision for doubtful accounts receivable and sales returns	205	3	31	(16)
Deferred income tax benefit	(84)	(1,298)	(1,195)	(1,687)
(Gain) loss on disposal of property and equipment		54	129	(57)
Extinguishment loss on long-term debt			1,386
Amortization of debt issuance costs	628	763	1,851	2,274
Amortization of debt original issuance discount	119	415	660	1,235
Amortization of debt discount	1,733		3,913
Changes in operating assets and liabilities:
Accounts receivable	(36,891)	8,776	(33,516)	54,069
Inventories	(4,833)	(2,046)	(31,184)	25,710
Prepaid expenses and other assets	(735)	534	741	2,344
Accounts payable	27,525	(24,727)	11,799	(70,993)
Accrued expenses and other liabilities	3,846	4,503	7,097	(440)
Net cash provided by (used in) operating activities	8,706	(5,712)	(6,942)	20,300
Cash flows from investing activities:
Capital expenditures and deposits on equipment	(3,784)	(4,253)	(11,179)	(9,995)
Restricted cash				181
Proceeds from sale of property and equipment	425		467	245
Net cash used in investing activities	(3,359)	(4,253)	(10,712)	(9,569)
Cash flows from financing activities:
Proceeds from long-term debt borrowing				5,179
Long-term debt payment	(5,954)	(4,163)	(17,689)	(12,448)
Payment for extinguishment of long-term debt			(938)
Payment of costs related to initial public offering (IPO)	(200)		(200)	(6)
Proceeds from borrowings under revolving line of credit	123,000	53,500	338,250	172,700
Repayments of borrowings under revolving line of credit	(123,000)	(53,500)	(338,250)	(172,700)
Proceeds from issuance of ordinary shares from share option exercises	348	41	348	41
Repurchase of ordinary shares				(124)
Net cash used in financing activities	(5,806)	(4,122)	(18,479)	(7,358)
Effect of exchange rate changes on cash and cash equivalents	(541)	3,450	(160)	1,709
Net increase (decrease) in cash and cash equivalents	(1,000)	(10,637)	(36,293)	5,082
Cash and cash equivalents at beginning of period	23,341	83,813	58,634	68,094
Cash and cash equivalents at end of period	22,341	73,176	22,341	73,176
Cash paid during the year:
Cash paid for interest	5,624	5,555	17,215	16,835
Cash paid for income taxes, net of refunds	3,522	1,700	5,293	3,009
Noncash activities information:
Capital expenditures included in accounts payable at period end	275	$ 1,367	275	$ 1,367
IPO costs included in accounts payable and accrued liabilities at period end	$ 1,990		1,990
Warrants issued in connection with debt			$ 21,341